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Abstract Here we report on the isolation of an Arabidopsis
thaliana cDNA that is able to complement a Saccharomyces
cerevisiae mutant unable to synthesise adenine. This cDNA
encodes a highly hydrophobic protein (ENT1,At) of 428 amino
acids, showing high similarity to the human nucleoside transpor-
ter hENT1. Yeast cells expressing ENT1,At are able to grow on
adenosine-containing media, adenosine import exhibited an
apparent affinity (KM) of 3.6 WM, and led to accumulation of
this nucleoside within the yeast cell. Transport is inhibited by
various nucleosides. Typical inhibitors of ENT-type nucleoside
transporters do not inhibit 3H-adenosine import. The presence of
protonophores abolished adenosine import, indicating that
ENT1,At catalyse a proton-dependent adenosine transport. This
is the first functional characterisation of a plant nucleoside
transport protein. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Nucleoside transport across human, animal, fungi and bac-
terial cell membranes has been intensively characterised in the
past at the physiological and molecular level [1^4]. The cor-
responding transport proteins mediating nucleoside transport
are classi¢ed into two groups: one group catalyses facilitated
di¡usion along a concentration gradient (ENT, equilibrative
nucleoside transporters) [5], whereas the members of the other
group (CNT, concentrative nucleoside transporters) are able
to transport nucleosides against an existing concentration gra-
dient [6]. Thus, the activity of the latter requires metabolic
energy and up to now both sodium or proton coupled nucleo-
side transport catalysed by CNT-type carriers have been iden-
ti¢ed [6,7].
The function of nucleoside import into animal cells is
mainly to allow nucleotide synthesis via salvage pathways in
cells lacking the capacity for de novo synthesis [1,8,9]. More-
over, adenosine functions as an extracellular messenger mol-
ecule [2], and is known to cause cell toxicity and immunosup-
pression, to in£uence cell morphology, to act as a vasodilator,
and to stimulate hormone secretion [10]. Therefore, transport
of these compounds plays an important role in the regulation
of cellular signalling and the regulation of metabolism and
development.
In contrast, our knowledge about the function of nucleo-
sides in plant cells and tissues is much more limited. In gen-
eral, plant cells harbour enzymes allowing nucleoside salvage
and some of the genes coding for these enzymes have been
identi¢ed at the molecular level [11,12]. In plants, nucleoside
uptake into the phloem tissue has been detected [13]. The
phloem represents a tubular system, consisting of living cells,
which allows long distance transport of organic products be-
tween plant organs [14]. These products are either generated
by photosynthesis, or liberated by degradation of various
storage products [14]. Cotyledons prepared from developing
castor-bean seedlings import nucleosides, which have previ-
ously been liberated from mobilising endosperm tissue [13].
In addition, intact petunia pollen cells are able to import
exogenous nucleosides via both an active import and a facili-
tated di¡usion [15,16]. Recently, a cDNA from Arabidopsis
thaliana coding for a protein with substantial similarity to
the human equilibrative nucleoside transporter 1 (hENT1)
has been described [17]. However, a proof of function of
this protein is still lacking [17]. Thus, the transport proteins
involved in the loading of nucleosides into phloem, or in-
volved in nucleoside uptake into other types of plant cells
are still unknown. Therefore, we set up an experimental ap-
proach to identify and characterise plant nucleoside transport-
ers at both the molecular and biochemical level.
We have used a Saccharomyces cerevisiae mutant, unable to
synthesise adenine, in an attempt to identify a cDNA in an A.
thaliana expression library coding for a nucleoside transport
protein. Yeast mutants have previously been shown to repre-
sent an extremely powerful experimental tool allowing the
identi¢cation of a wide range of homologous or heterologous
transport proteins. This approach was e¡ective in the identi-
¢cation and characterisation of a number of plant membrane
proteins that catalyse the transport of inorganic ions, or or-
ganic molecules across the plant plasma membrane [18]. Re-
cently, using this S. cerevisiae mutant a nucleoside transport
protein from the parasitic protozoan Trypanosoma brucei has
been identi¢ed [19].
2. Materials and methods
2.1. Enzymes and biochemicals
Restriction endonucleases and DNA-modifying enzymes were pur-
chased from Boehringer-Mannheim (Mannheim, Germany). Radioac-
tively labelled nucleosides were purchased from NEN. Amino acids to
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supplement auxotrophies were from Sigma (Deisenhofen, Germany).
Yeast nitrogen base without amino acids was from Remel (distributed
by Creatogen Biosciences, Augsburg, Germany).
2.2. Strains and growth conditions
For functional complementation the S. cerevisiae strain W303 (Mat
K, leu2-3, leu2-112, trp1-1, ura3-1, his3-11, his3-15, ade2-1, can1-100)
was used [20]. Growth of yeast under non-selective conditions was
performed in YPD medium (1% (w/v) yeast extract, 2% (w/v) bacto-
peptone, 2% (w/v) glucose). Yeast cells were grown at 30‡C either in
liquid culture with vigorous shaking, or on agar plates (media supple-
mented with 20 g agar/l). Escherichia coli cells (XL1Blue, Stratagene,
Heidelberg, Germany) were grown in YT medium (0.8% peptone,
0.5% yeast extract, and 0.25% NaCl) with or without ampicillin
(200 mg/l) and tetracycline (10 mg/l).
2.3. Preparation of library DNA and yeast transformation
The cDNA expression library derived from whole A. thaliana seed-
lings in the yeast expression vector pFL61 [21] was a kind gift from
Dr. Miche'le Minet (CNRS, Gif-sur-Yvette, France). The library was
ampli¢ed as explained before [22]. 1 Wg of library plasmid was used
for yeast transformation according to a standard protocol [23]. Out of
104 transformants selected on synthetic minimal media lacking uracil
and adenine but containing 150 WM adenosine, one colony grew. The
library plasmid was isolated as given in [24] and retransformed into E.
coli. For sequencing of the ENT1,At cDNA from plasmid pTM86, the
oligonucleotides 5P-GTTTTCAAGTTCTTAGATGC-3P, reading from
the PGK promotor towards the insert and 5P-AGCGTAAAG-
GATGGGG-3P reading from the PGK terminator towards the insert
[21] were used. Sequencing was performed by ‘Seqlab’ Sequencing
Laboratories, (Go«ttingen, Germany).
2.4. Plasmids and DNA constructions
As a control in uptake experiments, plasmid pTM88, harbouring
the ENT1,At cDNA in antisense orientation in respect to the PGK
promotor, was generated. The complete coding region of the ENT1,At
cDNA was ampli¢ed by polymerase chain reaction (PCR) with pfu-
DNA polymerase using primers TM41 (5P-CAAATGACCACCACC-
GATAAATC-3P) and TM42 (5P-GAATCAAATGACCCAGAAC-
CAAG-3P). After ¢lling in the NotI digested restriction sites of vector
p£61, the PCR product was inserted in the correct orientation as
checked by restriction digestion.
2.5. Transport experiments
For transport experiments, yeast cells were retransformed with plas-
mid pTM86. Yeast cells were grown in minimal media containing
adenine, but lacking uracil. Cells were grown to an OD600 of 0.5 to
1.5, harvested, washed twice with 25 mM NaPO4 bu¡er medium (pH
6.0) and resuspended in the same bu¡er medium resulting in a ¢nal
OD600 of 10. Cells were kept on ice until transport experiments were
initiated. 100 Wl of cells were added to the same volume of transport
medium containing [3H]adenosine in NaPO4 bu¡er medium (if not
indicated otherwise), and incubated at 30‡C. At the end of the incu-
bation, cells were ¢ltered on membrane ¢lters (Supor membrane disc
¢lters, 0.45 Wm pore size, Pall Gelman Laboratory, USA), previously
set under vacuum.
3. Results
3.1. Complementation of a S. cerevisiae mutant unable to
synthesise adenine
The S. cerevisiae strain mutant W303 is not able to synthe-
sise adenine. Therefore, to grow this mutant, adenine has
either to be present in the medium (Fig. 1A), or a transport
protein has to catalyse adenosine import, which subsequently
is converted in the yeast cell to adenine. After transformation
of the mutated yeast cells with an A. thaliana cDNA library
[21] we identi¢ed one yeast colony able to grow on minimal
media containing adenosine (Fig. 1B). Wild-type cells, as well
as cells harbouring the control plasmid pTM88 grow on ad-
enine-containing medium, but not on medium supplemented
with adenosine (Fig. 1B).
Sequence analysis of the plasmid (pTM86) isolated from the
transformed cells revealed that the cDNA insert (1596 bp) was
identical to an A. thaliana genomic sequence (AAC18807;
PID g3176684), and contained a 36 bp untranslated region
at the 5P-end, and 273 bp untranslated region at the 3P-end.
Recently, a similar cDNA was isolated but the deduced amino
acid sequence di¡ered in two positions, namely at amino acid
position 89 a proline instead of a leucine residue was deter-
mined, and at amino acid position 410 a threonine instead of
a methionine residue was identi¢ed [17]. However, the authors
sequenced a PCR product [17] and it may be that failure
function of the polymerase caused these discrepancies.
The cDNA identi¢ed by us encodes a highly hydrophobic
protein of 428 amino acids, exhibiting 11 predicted membrane
spanning segments (analysis according to [25]). The deduced
Fig. 1. Adenosine utilisation in S. cerevisiae. A: Growing yeast cells harbouring ENT1,At (1), control vector (2), or wild-type yeast cells (3) on
agar containing 150 WM adenine. B: Growing yeast cells harbouring ENT1,At (1), control vector (2), or wild-type yeast cells (3) grown on min-
imal media containing 150 WM adenosine.
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protein shares 24% identical amino acids to both the hENT1
and the equilibrative nucleoside transporter mENT3 from
mouse. Therefore, we named the protein ENT1,At. The
ENT1,At protein also exhibits high sequence similarity to 7
other A. thaliana proteins that have also not been functionally
characterised so far. These sequences have the following NCB
accession numbers and the deduced proteins exhibit following
degrees of identity: AAG10625 exhibiting an identity of 45%,
CAB81054 exhibiting an identity of 28%, AAF04424 exhibit-
ing an identity of 28%, CAB81053 exhibiting an identity of
26%, CAB81055 exhibiting an identity of 26%, CAB81056
exhibiting an identity of 26%, and AAD25545 exhibiting an
identity of 26%.
3.2. Transport characteristics of ENT1,At
To characterise the function of ENT1,At we ¢rst analysed
the time dependency of [3H]adenosine uptake. Adenosine im-
port into yeast cells harbouring plasmid pTM86 was linear
with time for about 10 min and then reached saturation at
about 2.5 pmol adenosine/107 cells (Fig. 2A; we checked in
further control experiments, that uptake was linear for about
10 min also at adenosine concentrations of up to 50 WM, data
not shown). Assuming a yeast cell volume of 1 Wl/3U107 cells,
the externally given 3H-adenosine (1.8 WM) has been concen-
trated by a factor of about 4.2. Yeast cells harbouring the
control plasmid pTM88 showed almost no adenosine import
over a time span of up to 45 min (Fig. 2A). The same holds
true for wild-type yeast cells (data not shown). Uptake of
adenosine displayed typical Michaelis^Menten-type kinetics
(Fig. 2B) and an apparent a⁄nity (KM) of 3.6 WM (inset
Fig. 2B).
To analyse whether ENT1,At functions as an equilibrative,
or as a concentrative adenosine transporter we added the un-
coupler carbonyl cyanide m-chlorophenyl-hydrazone (CCCP;
5 WM ¢nal concentration) during uptake. As demonstrated in
Fig. 2A, CCCP completely abolished adenosine uptake, which
is consistent with the strong inhibitory e¡ect of dinitrophenol
(DNP) on adenosine import catalysed by ENT1,At (Table 1).
Replacement of sodium phosphate by potassium phosphate in
Fig. 2. Transport kinetics of [3H]adenosine import in intact yeast
cells. A: Time dependency of adenosine transport. Yeast cells har-
bouring ENT1,At were at a [3H]adenosine concentration of 1.8 WM.
8, cells harbouring ENT1,At ; F, a control vector; R, adenosine
transport by cells harbouring ENT1,At in the presence of 5WM
CCCP. B: Michaelis^Menten kinetics of adenosine import. Cells
were incubated for 7 min in incubation medium containing the indi-
cated concentrations of [3H]adenosine. Inset: Eadie^Hofstee plot of
the data indicating an apparent a⁄nity of 3.6 WM. Uptake rates
into control cells has been subtracted. Data are the mean of three
independent experiments. Standard error of the mean less than 4%
of the given value.
Table 1
Inhibition of ENT1,At mediated [3H]adenosine uptake in intact
yeast cells by nucleotides, nucleobases and related substances
Additive [3H]Adenosine uptake (% of control)
None 100
Nucleosides:
Adenosine 26
Cytidine 53
Guanosine 76
Uridine 93
Inosine 53
2P-Deoxyadenosine 21
2P-Deoxycytidine 42
2P-Deoxyguanosine 59
2P-Deoxythymidine 72
2P-Deoxyinosine 71
Nucleobases:
Adenine 90
Cytosine 107
Guanine 91
Thymine 101
Uracil 117
Hypoxanthine 112
Nucleotides:
dATP 91
ATP 95
ADP 99
AMP 99
CTP 87
GTP 91
UTP 97
NAD 97
Inhibitors:
Dilazep (20 nM) 105
Dilazep (20 WM) 105
Dipyridamole (20 nM) 115
Dipyridamole (20 WM) 98
NBMPR (20 nM) 75
NBMPR (20 WM) 67
DNP (1 mM) 4
[3H]Adenosine uptake was performed at a substrate concentration
of 1.8 WM for 7 min. Inhibitor concentrations were 18 WM (if not
stated otherwise). Data are the mean of three independent experi-
ments. Standard error of the mean less than 4% of the given value.
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the incubation medium does not inhibit adenosine import
(data not shown). Furthermore, we analysed the e¡ect of typ-
ical inhibitors of mammalian ENTs such as nitrobenzylmer-
captopurine (NBMPR), dilazep, and dipyridamole [1].
NBMPR given at a high concentration (20 nM) inhibited
adenosine import by about 25%, whereas both dilazep, and
dipyridamole did not a¡ect transport activity of ENT1,At
(Table 1).
To assess the substrate speci¢city of ENT1,At in more de-
tail we examined the e¡ect of structurally related compounds
on adenosine import. Unlabelled adenosine, and deoxyadeno-
sine showed the highest inhibition, followed by inosine, cyti-
dine and the corresponding 2P-deoxynucleosides. Guanosine
exerted little e¡ect on adenosine transport, all other substan-
ces tested had no e¡ect (Table 1). IC50 values were determined
at a substrate concentration of 3.6 WM adenosine for 2-deoxy-
adenosine (4 WM), inosine (20 WM), cytidine (20 WM) and
guanosine (28 WM). Thus ENT1,At represents a high a⁄nity
adenosine transporter which also exhibits a⁄nity to other
nucleosides.
4. Discussion
ENT1,At has been identi¢ed by functional complementa-
tion of the yeast mutant W303 and represents the ¢rst plant
nucleoside transport protein described at the biochemical lev-
el. This transporter exhibits a high a⁄nity to adenosine (3.6
WM; Fig. 2B) and is inhibited to 21^76% residual activity by
both purine and pyrimidine nucleosides, as well as by 2P-de-
oxynucleosides (Table 1). Thus ENT1,At is most likely a
transport protein with broad substrate speci¢city. The inhib-
itory e¡ect of various nucleosides on adenosine transport by
ENT1,At (Table 1) is in accordance with the biochemical
properties of other nucleoside transporters. Members of
both the CNT- and the ENT-type mammalian nucleoside
transport proteins transport more than one nucleoside [1].
Interestingly, uridine did not substantially inhibit adenosine
transport by ENT1,At (Table 1). As uridine is considered to
represent a universal permeant transported by all mammalian
nucleoside transport proteins [6], the ENT1,At protein di¡ers
in this biochemical property.
Both the predicted topology of ENT1,At with 11 transmem-
brane domains, and the high sequence similarity to the known
ENT-type transport proteins supported the assumption that
ENT1,At might catalyse an equilibrative nucleoside transport
[17]. However, the inhibitory e¡ect of the protonophores
CCCP and DNP (Fig. 2 and Table 1) clearly indicate that
this is not the case. Obviously, the proton gradient across
the yeast plasma membrane is required to mediate adenosine
import into intact yeast cells. The required proton motive
force to allow a concentrative nucleoside import into plant
cells could be generated by a highly active ATPase, known
to reside in the plasmalemma [26].
Categorisation of ENT1,At as a concentrative type of nu-
cleoside transporter is further supported by the lack of e¡ect
of the inhibitors dilazep, and dipyridamole on ENT1,At ac-
tivity (Table 1). Typically, these compounds are classi¢ed as
ENT speci¢c inhibitors, which do not a¡ect CNT-type nucleo-
side transporters [6]. NBMPR given at a concentration of 20
nM decreased ENT1,At activity to about 75% of the corre-
sponding control rate (Table 1). In contrast to dilazep and
dipyridamole, the ribonucleoside NBMPR also inhibits con-
centrative-type nucleoside transporters at high concentrations.
However, ENT-type transporters exhibit IC50 values between
5 nM and 1 WM for highly sensitive or slightly sensitive trans-
porters, respectively [6]. To this point we cannot explain why
NBMPR given at 20 WM inhibited ENT1,At-mediated adeno-
sine transport only slightly stronger than at 20 nM (Table 1).
Obviously, further experiments have to be carried out on ad-
enosine transporters from plants to gain deeper insight into
the biochemical properties.
Both the A. thaliana transport protein ENT1, and the nu-
cleoside transporter TbNT2 from T. brucei (TbNT2) share
structurally a higher similarity to ENT-like nucleoside trans-
porters than to CNT-like nucleoside transporters (see above
and [27]). However, both proteins catalyse a proton driven
nucleoside transport (Fig. 1A) [27]. Therefore, it is not possi-
ble to take the predicted molecular architecture of a nucleo-
side transport protein as an indicator for this general bio-
chemical feature. Interestingly, a detailed phylogenetic
analysis revealed that the predicted nucleoside transporters
present in the genome of A. thaliana cluster closer to homol-
ogous proteins from parasitic protozoa than to all other eu-
karyotic nucleoside transport proteins [5]. It remains to be
analysed whether the plant transporters share further bio-
chemical properties with the parasitic proteins.
The proton dependency of adenosine transport catalysed by
ENT1,At concurs with previous measurements of purine nu-
cleoside import into enriched petunia pollen cells [15]. Fur-
thermore, nucleoside transport into petunia pollen cells was
not sensitive to low concentrations of NBMPR [15]. Up to
now it is not known whether ENT1,At is a pollen speci¢c
transporter and such cell speci¢city would contrast with pre-
vious data. Li and Wang [17] showed that ENT1,At mRNA
accumulated to similar levels in both autotrophic and hetero-
trophic tissues from A. thaliana. Thus, it will be very interest-
ing in the near future to analyse both the cell speci¢city of
expression, and the biochemical properties of all eight puta-
tive nucleoside transporters from A. thaliana in more detail.
In general, little is known about the nucleoside levels in
di¡erent plant cells and plant cell compartments. Enzymes
involved in salvage reactions of purines and pyrimidines
have been identi¢ed on the enzymatic and molecular level
[11,12] and A. thaliana mutants lacking an enzyme of the
nucleoside salvage pathways show non-functional pollen and
thus male sterility [28]. Therefore, the possible involvement of
nucleoside transport proteins in plant cell physiology will be
very interesting to study in the near future. Moreover, it has
been shown that nucleoside transport into pollen cells occurs
by both an active and a passive transport mechanism [15,16].
Therefore, the molecular nature of the transport protein me-
diating passive nucleoside transport is still in question.
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